April 25, 2013
Emergent BioSolutions to Acquire Healthcare Protective Products Division of Bracco Diagnostics Inc.
Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into an asset purchase agreement to acquire the Healthcare…
April 24, 2013
NIAMS Clinical Trial Outcome Instrument Development Grant Program (U01) – Feb 07, 2014
... Funding Opportunity Number: RFA-AR-14-008 Opportunity Category: Discretionary Funding Instrument Type: Cooperative Agreement Category of Funding Activity: Health CFDA Number:…
April 24, 2013
Enhancing post-market surveillance through developing registries for medical device epidemiology (U01) – Apr 30, 2017
... Funding Opportunity Number: PAR-13-202 Opportunity Category: Discretionary Funding Instrument Type: Cooperative Agreement Category of Funding Activity: Consumer ProtectionHealth CFDA…
April 24, 2013
MedImmune acquires Ann Arbor start-up AlphaCore Pharma
MedImmune has acquired Ann Arbor-based AlphaCore Pharma, creating another exit for a local up-and-coming start-up. MedImmune, the global biologics research…
April 24, 2013
NHLBI SBIR Phase IIB Bridge Awards, NHLBI – NIH
The purpose of the NHLBI SBIR Phase IIB Bridge Award is to facilitate and accelerate the capital-intensive steps that are…
